本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kura Oncology, Inc

10.85
-0.3550-3.17%
盤後10.75-0.1000-0.92%19:14 EST
成交量:272.41萬
成交額:3,018.75萬
市值:9.44億
市盈率:-4.37
高:11.50
開:11.16
低:10.77
收:11.21
52周最高:16.68
52周最低:5.41
股本:8,701.75萬
流通股本:6,398.56萬
量比:0.97
換手率:4.26%
股息:- -
股息率:- -
每股收益(TTM):-2.4801
每股收益(LYR):-2.0193
淨資產收益率:-65.10%
總資產收益率:-26.57%
市淨率:3.89
市盈率(LYR):-5.37

資料載入中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/02

重要事件披露

Form 8-K - Current report
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report